CIK 0001861123 · <br>Emerging growth company
Eikon Therapeutics, Inc.
Sign in to watch- Ticker
- EIKN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 842807586
- Phone
- 341-777-0566
- Business address
- 230 HARRIET TUBMAN WAY, MILLBRAE, CA, 94030
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Results of operations
- 10-K Report Annual Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13D Stake Beneficial Ownership Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Conversion See remarks acquired 284,857 shares (conversion)
- 4 Open-market buy 10% owner bought 2,117,760 shares at $18.00 ($38,119,680)
- 4 Open-market buy 10% owner bought 55,555 shares at $18.00 ($999,990)
- 4 Open-market buy Director bought 111,111 shares at $18.00 ($1,999,998)
- 4 Open-market buy Director bought 277,776 shares at $18.00 ($4,999,968)
- 4 Open-market buy 10% owner bought 277,776 shares at $18.00 ($4,999,968)
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 2 of 4 · 69 filings